JP2024533264A5 - - Google Patents
Info
- Publication number
- JP2024533264A5 JP2024533264A5 JP2024514643A JP2024514643A JP2024533264A5 JP 2024533264 A5 JP2024533264 A5 JP 2024533264A5 JP 2024514643 A JP2024514643 A JP 2024514643A JP 2024514643 A JP2024514643 A JP 2024514643A JP 2024533264 A5 JP2024533264 A5 JP 2024533264A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrimidine
- chloro
- amine
- aminopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163260944P | 2021-09-07 | 2021-09-07 | |
| US63/260,944 | 2021-09-07 | ||
| PCT/US2022/075969 WO2023039370A1 (en) | 2021-09-07 | 2022-09-06 | Methods for treating neurogenerative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533264A JP2024533264A (ja) | 2024-09-12 |
| JP2024533264A5 true JP2024533264A5 (https=) | 2025-09-17 |
Family
ID=85506888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514643A Pending JP2024533264A (ja) | 2021-09-07 | 2022-09-06 | 神経原性疾患を処置するための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240374602A1 (https=) |
| EP (1) | EP4398988A4 (https=) |
| JP (1) | JP2024533264A (https=) |
| CN (1) | CN118401243A (https=) |
| CA (1) | CA3231001A1 (https=) |
| MX (1) | MX2024002887A (https=) |
| WO (1) | WO2023039370A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202108519TA (en) | 2019-02-13 | 2021-09-29 | Ptc Therapeutics Inc | Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia |
| WO2020167624A1 (en) | 2019-02-13 | 2020-08-20 | Ptc Therapeutics, Inc. | Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1470356A1 (de) * | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
| US5654307A (en) * | 1994-01-25 | 1997-08-05 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| WO2004065392A1 (en) * | 2003-01-24 | 2004-08-05 | Smithkline Beecham Corporation | Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| WO2012012656A2 (en) * | 2010-07-21 | 2012-01-26 | University Of South Florida | Materials and methods for treating neurodegenerative diseases |
| CN115209955A (zh) * | 2019-12-12 | 2022-10-18 | Ptc医疗公司 | 治疗家族性自主神经功能障碍的化合物 |
-
2022
- 2022-09-06 MX MX2024002887A patent/MX2024002887A/es unknown
- 2022-09-06 WO PCT/US2022/075969 patent/WO2023039370A1/en not_active Ceased
- 2022-09-06 CA CA3231001A patent/CA3231001A1/en active Pending
- 2022-09-06 EP EP22868238.1A patent/EP4398988A4/en active Pending
- 2022-09-06 US US18/689,680 patent/US20240374602A1/en active Pending
- 2022-09-06 JP JP2024514643A patent/JP2024533264A/ja active Pending
- 2022-09-06 CN CN202280074008.5A patent/CN118401243A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230120185A1 (en) | Heterocyclic amides as kinase inhibitors | |
| JP7202373B2 (ja) | ジヒドロピリミジン化合物、及び医薬におけるその使用 | |
| JP2024540445A5 (https=) | ||
| JP5412429B2 (ja) | 抗細菌性アミド及びスルホンアミド置換複素環式尿素化合物 | |
| JP2024533264A5 (https=) | ||
| US20190345138A1 (en) | Heterocyclic amides as kinase inhibitors | |
| AU2015304851A1 (en) | Heterocyclic amides as RIP1 kinase inhibitors as medicaments | |
| EP2699557B1 (en) | 3-(oxazol-2-yl-ethoxy)- and 3-(thiazol-2-yl-ethoxy)-benzamide derivatives as anti-bacterial agents | |
| IL317705A (en) | Compounds for the treatment of spinocerebellar ataxia type 3 | |
| CA2969090A1 (en) | Triazolopyrimidine compounds and uses thereof | |
| RU2013138717A (ru) | Конденсированные производные аминодигидротиазина, пригодные в качестве ингибиторов васе | |
| RS54725B1 (sr) | Benzen sulfonamid tiazol i jedinjenja oksazola | |
| RS54782B1 (sr) | Novi heterociklični derivati i njihova upotreba u tretmanu neuroloških poremećaja | |
| CA2610888A1 (en) | Inhibitors of akt activity | |
| JP2023506488A5 (https=) | ||
| JP2019504901A5 (https=) | ||
| US20230192676A1 (en) | Heterocyclic Amides as Kinase Inhibitors | |
| US20170231931A1 (en) | Products for the treatment and prevention of neurological disorders coursing with a cognition deficit or impairment, and of neurodegenerative diseases | |
| JP2022546414A5 (https=) | ||
| JP2017523223A5 (https=) | ||
| JP2016523963A5 (https=) | ||
| JP2006512366A5 (https=) | ||
| AU2005271669A1 (en) | 1,3-disubstituted heteroaryl NMDA/NR2B antagonists | |
| JP2024533263A5 (https=) | ||
| JP2008503575A5 (https=) |